- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (280)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (2)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3708)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2023 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251 [PMID: 37545638 DOI: 10.3748/wjg.v29.i27.4236] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i27/4236.htm |
| Number | Citing Articles |
| 1 |
Mei‐Tong Nie, Pei‐Qin Wang, Pei‐Mei Shi, Xia‐Lu Hong, Xin Zhang, Baoyu Xiang, Menghui Zhang, Wei‐Fen Xie. Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis. Journal of Gastroenterology and Hepatology 2024; 39(4): 762 doi: 10.1111/jgh.16484
|
| 2 |
Mazen Elsheikh, Ahmed El Sabagh, Islam B Mohamed, Megha Bhongade, Manal M Hassan, Prasun Kumar Jalal. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management. World Journal of Gastroenterology 2023; 29(46): 6028-6048 doi: 10.3748/wjg.v29.i46.6028
Abstract(187) |
Core Tip(208) |
Full Article(HTML)(1862)
|
Full Article with Cover (PDF)-1369K(56)
|
Full Article (Word)-615K(19)
|
Audio-631K(1)
|
Peer-Review Report-216K(22)
|
Answering Reviewers-281K(21)
|
Full Article (PDF)-1145K(130)
|
Full Article (XML)-412K(18)
|
Times Cited (1)
|
Total Visits (3191)
|
Open
|
| 3 |
Yifan Cui, Mingming Zhang, Jing Guo, Jin Jin, Haijiao Wang, Xinran Wang. Correlation between sarcopenia and cirrhosis: a meta-analysis. Frontiers in Nutrition 2024; 10 doi: 10.3389/fnut.2023.1342100
|
| 4 |
Youle Zheng, Jin Feng, Yixin Yu, Min Ling, Xu Wang. Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies. Archives of Pharmacal Research 2024; 47(4): 301 doi: 10.1007/s12272-024-01493-2
|
| 5 |
艳 刘. Prognostic Value of Preoperative Myosteatosis Combined with Albumin-Globulin Score in Patients with Cholangiocarcinoma after Radical Surgery. Advances in Clinical Medicine 2024; 14(03): 900 doi: 10.12677/ACM.2024.143789
|
| 6 |
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of Clinical Medicine 2024; 13(3): 919 doi: 10.3390/jcm13030919
|
| 7 |
皓月 田. The Application of Rifaximin in Patients with End Stage Liver Disease. Advances in Clinical Medicine 2024; 14(01): 466 doi: 10.12677/ACM.2024.141067
|
| 8 |
Hiroki Nishikawa, Soo Ki Kim, Akira Asai. Body Composition in Chronic Liver Disease. International Journal of Molecular Sciences 2024; 25(2): 964 doi: 10.3390/ijms25020964
|